Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Cem Griffiths"'
Autor:
Rungapiromnan W; Centre for Pharmacoepidemiology and Drug Safety, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK., Mason KJ; Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK., Lunt M; Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK., McElhone K; Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK., Burden AD; Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK., Rutter MK; Division of Endocrinology, Diabetes and Gastroenterology, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.; Manchester Diabetes Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK., Warren RB; Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.; Dermatology Centre, Salford Royal NHS Foundation Trust, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK., Griffiths CEM; Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.; Dermatology Centre, Salford Royal NHS Foundation Trust, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK., Ashcroft DM; Centre for Pharmacoepidemiology and Drug Safety, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Publikováno v:
Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2020 Apr; Vol. 34 (4), pp. 769-778. Date of Electronic Publication: 2019 Nov 19.
Autor:
Dand N; School of Basic & Medical Biosciences, London, United Kingdom., Duckworth M; St John's Institute of Dermatology, Faculty of Life Sciences & Medicine, London, United Kingdom., Baudry D; St John's Institute of Dermatology, Faculty of Life Sciences & Medicine, London, United Kingdom., Russell A; St John's Institute of Dermatology, Faculty of Life Sciences & Medicine, London, United Kingdom., Curtis CJ; NIHR Maudsley Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, United Kingdom; Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom., Lee SH; NIHR Maudsley Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, United Kingdom; Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom., Evans I; Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, University of Manchester, Manchester, United Kingdom., Mason KJ; Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, University of Manchester, Manchester, United Kingdom., Alsharqi A; Royal Liverpool and Brodgreen University Hospital Trusts, Liverpool, United Kingdom., Becher G; Alan Lyell Centre for Dermatology, West Glasgow ACH, Glasgow, United Kingdom., Burden AD; Institute of Infection, Inflammation and Immunity, University of Glasgow, Glasgow, United Kingdom., Goodwin RG; Aneurin Bevan University Health Board, Gwent, United Kingdom., McKenna K; Department of Dermatology, Belfast City Hospital, Belfast, United Kingdom., Murphy R; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom; Sheffield Children's NHS Foundation Trust, Sheffield, United Kingdom; Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom., Perera GK; Chelsea & Westminster Hospital NHS Foundation Trust, West Middlesex University Hospital, London, United Kingdom., Rotarescu R; University Hospitals of North Midlands, Stoke-on-Trent, United Kingdom., Wahie S; University Hospital North Durham, Durham, United Kingdom., Wright A; Centre for Skin Science, University of Bradford, Bradford, United Kingdom; Dermatology Department, St Luke's Hospital, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, United Kingdom., Reynolds NJ; Dermatological Sciences, Institute of Cellular Medicine, Newcastle University Medical School, Newcastle upon Tyne, United Kingdom; Department of Dermatology, Royal Victoria Infirmary, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom; Newcastle MRC/EPSRC Molecular Pathology Node, Newcastle University, Newcastle upon Tyne, United Kingdom., Warren RB; Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, University of Manchester, Manchester, United Kingdom., Griffiths CEM; Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, University of Manchester, Manchester, United Kingdom., Smith CH; St John's Institute of Dermatology, Faculty of Life Sciences & Medicine, London, United Kingdom., Simpson MA; School of Basic & Medical Biosciences, London, United Kingdom. Electronic address: michael.simpson@kcl.ac.uk., Barker JN; St John's Institute of Dermatology, Faculty of Life Sciences & Medicine, London, United Kingdom. Electronic address: jonathan.barker@kcl.ac.uk.
Publikováno v:
The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2019 Jun; Vol. 143 (6), pp. 2120-2130. Date of Electronic Publication: 2018 Dec 20.
Autor:
Foulkes AC; The Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK. Electronic address: Amy.foulkes@manchester.ac.uk., Watson DS; Centre for Translational Bioinformatics, William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London, UK., Carr DF; Wolfson Centre for Personalised Medicine, The University of Liverpool, Liverpool, UK., Kenny JG; Centre for Genomic Research, The University of Liverpool, Liverpool, UK., Slidel T; MedImmune Ltd, Sir Aaron Klug Building, Granta Park Cambridge, UK., Parslew R; Dermatology Department, Kent Lodge, Broadgreen Hospital, Liverpool, UK., Pirmohamed M; Wolfson Centre for Personalised Medicine, The University of Liverpool, Liverpool, UK., Anders S; Centre for Molecular Biology of the University of Heidelberg (ZMBH), Heidelberg, Germany., Reynolds NJ; Institute of Cellular Medicine, Newcastle University and Department of Dermatology, Royal Victoria Infirmary, Newcastle upon Tyne, UK., Griffiths CEM; The Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK., Warren RB; The Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK., Barnes MR; Centre for Translational Bioinformatics, William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London, UK.
Publikováno v:
The Journal of investigative dermatology [J Invest Dermatol] 2019 Jan; Vol. 139 (1), pp. 100-107. Date of Electronic Publication: 2018 Jul 17.
Autor:
Yiu ZZN; Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK; Centre for Pharmacoepidemiology and Drug Safety, School of Health Sciences, The University of Manchester, Manchester, UK. Electronic address: zenas.yiu@manchester.ac.uk., Smith CH; St. John's Institute of Dermatology, Guy's and St. Thomas' NHS Foundation Trust, London, UK., Ashcroft DM; Centre for Pharmacoepidemiology and Drug Safety, School of Health Sciences, The University of Manchester, Manchester, UK., Lunt M; Arthritis Research UK Epidemiology unit, The University of Manchester, Manchester, UK., Walton S; Department of Dermatology, Castle Hill Hospital, Hull, UK., Murphy R; Sheffield University Teaching Hospitals and Sheffield Children's Hospitals, Sheffield, UK., Reynolds NJ; Dermatological Sciences, Institute of Cellular Medicine, Medical School, Newcastle University, and Department of Dermatology, Royal Victoria Infirmary, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Ormerod AD; Division of Applied Medicine, University of Aberdeen, Foresterhill, Aberdeen, UK., Griffiths CEM; Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK., Warren RB; Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK. Electronic address: richard.warren@manchester.ac.uk.
Publikováno v:
The Journal of investigative dermatology [J Invest Dermatol] 2018 Mar; Vol. 138 (3), pp. 534-541. Date of Electronic Publication: 2017 Oct 17.
Autor:
Davison NJ; Manchester Centre for Health Economics, The University of Manchester, Manchester, U.K.; BADBIR (on behalf of the PSORT consortium), The University of Manchester, Manchester, U.K., Warren RB; The Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, Manchester, U.K., Mason KJ; BADBIR (on behalf of the PSORT consortium), The University of Manchester, Manchester, U.K., McElhone K; BADBIR (on behalf of the PSORT consortium), The University of Manchester, Manchester, U.K., Kirby B; Department of Dermatology, St Vincent's University Hospital, Dublin, Ireland., Burden AD; Department of Dermatology, Western Infirmary, Glasgow, U.K., Smith CH; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, U.K., Payne K; Manchester Centre for Health Economics, The University of Manchester, Manchester, U.K., Griffiths CEM; The Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, Manchester, U.K.
Publikováno v:
The British journal of dermatology [Br J Dermatol] 2017 Sep; Vol. 177 (3), pp. 828-836. Date of Electronic Publication: 2017 Jul 26.
Autor:
Iskandar IYK; Centre for Pharmacoepidemiology and Drug Safety, Manchester Pharmacy School, The University of Manchester, Manchester Academic Health Science Centre, Room 1·134, 1st Floor, Stopford Building, Oxford Road, Manchester, M13 9PT, U.K., Ashcroft DM; Centre for Pharmacoepidemiology and Drug Safety, Manchester Pharmacy School, The University of Manchester, Manchester Academic Health Science Centre, Room 1·134, 1st Floor, Stopford Building, Oxford Road, Manchester, M13 9PT, U.K., Warren RB; Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, Manchester, U.K., Evans I; Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, Manchester, U.K., McElhone K; Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, Manchester, U.K., Owen CM; Department of Dermatology, East Lancashire Hospitals NHS Trust, Royal Blackburn Hospital, Blackburn, U.K., Burden AD; Department of Dermatology, Western Infirmary, Glasgow, U.K., Smith CH; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, U.K., Reynolds NJ; Dermatological Sciences, Institute of Cellular Medicine, Medical School, Newcastle University, Newcastle upon Tyne, U.K.; Department of Dermatology, Royal Victoria Infirmary, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, U.K., Griffiths CEM; Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, Manchester, U.K.
Publikováno v:
The British journal of dermatology [Br J Dermatol] 2017 May; Vol. 176 (5), pp. 1297-1307. Date of Electronic Publication: 2017 Mar 20.
Publikováno v:
The British journal of dermatologyReferences. 185(5)
The management of moderate-to-severe psoriasis has been transformed by the introduction of biological therapies. These medicines, particularly those targeting interleukin (IL)-17 and IL-23p19, can offer clear or nearly clear skin for the majority of
Autor:
Richard B. Warren, Niall J Davison, A. D. Burden, Kathleen McElhone, Brian Kirby, Katherine Payne, K.J. Mason, Catherine H. Smith, Cem Griffiths
Publikováno v:
Davison, N J, Warren, R B, Mason, K J, McElhone, K, Kirby, B, Burden, A D, Smith, C H, Payne, K & Griffiths, C E M 2017, ' Identification of factors that may influence the selection of first-line biologic therapy for people with psoriasis : a prospective, multi-centre cohort study ', British Journal of Dermatology, vol. 177, no. 3, pp. 828-836 . https://doi.org/10.1111/bjd.15551
BACKGROUND: The Psoriasis Stratification to Optimise Relevant Therapy (PSORT) consortium has a collective aim to develop a prescribing algorithm to help stratify eligible psoriasis patients to the most appropriate biologic treatment. To facilitate th
Autor:
Kathleen McElhone, Cem Griffiths, I.Y.K. Iskandar, C. M. Owen, Ian Evans, Catherine H. Smith, Nick J. Reynolds, A. D. Burden, Richard B. Warren, Darren M. Ashcroft
Publikováno v:
Iskandar, I Y K, Ashcroft, D M, Warren, R B, Evans, I, McElhone, K, Owen, C M, Burden, A D, Smith, C H, Reynolds, N J & Griffiths, C E M 2017, ' Patterns of biologic therapy use in the management of psoriasis : cohort study from the British Association of Dermatologists Biologic Interventions Register (BADBIR) ', British Journal of Dermatology, vol. 176, pp. 1297-1307 . https://doi.org/10.1111/bjd.15027
BACKGROUND: Treatment modifications, including dose-escalations, dose-reductions, switches, discontinuations and restarts of biologics may be necessary in the management of psoriasis but the patterns of usage are incompletely defined.OBJECTIVES: To e